<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>442</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>11098050</PubmedId>
            <Abstract>Von Willebrand factor (vWF) is a multimeric glycoprotein that mediates platelet adhesion and thrombus formation at sites of vascular injury. vWF functions as a molecular bridge between collagen and platelet receptor glycoprotein Ib. The major collagen-binding site of vWF is contained within the A3 domain, but its precise location is unknown. To localize the collagen-binding site, we determined the crystal structure of A3 in complex with an Fab fragment of antibody RU5 that inhibits collagen binding. The structure shows that RU5 recognizes a nonlinear epitope consisting of residues 962-966, 981-997, and 1022-1026. Alanine mutants were constructed of residues Arg(963), Glu(987), His(990), Arg(1016), and His(1023), located in or close to the epitope. Mutants were expressed as fully processed multimeric vWF. Mutation of His(1023) abolished collagen binding, whereas mutation of Arg(963) and Arg(1016) reduced collagen binding by 25-35%. These residues are part of loops alpha3beta4 and alpha1beta2 and alpha-helix 3, respectively, and lie near the bottom face of the domain. His(1023) and flanking residues display multiple conformations in available A3-crystal structures, suggesting that binding of A3 to collagen involves an induced-fit mechanism. The collagen-binding site of A3 is located distant from the top face of the domain where collagen-binding sites are found in homologous integrin I domains.</Abstract>
            <ArticleYear>2001</ArticleYear>
            <ArticlePages>9985-91</ArticlePages>
            <ArticleTitle>Identification of the collagen-binding site of the von Willebrand factor A3-domain.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Romijn</LastName>
                    <ForeName>R A</ForeName>
                </Author>
                <Author>
                    <LastName>Bouma</LastName>
                    <ForeName>B</ForeName>
                </Author>
                <Author>
                    <LastName>Wuyster</LastName>
                    <ForeName>W</ForeName>
                </Author>
                <Author>
                    <LastName>Gros</LastName>
                    <ForeName>P</ForeName>
                </Author>
                <Author>
                    <LastName>Kroon</LastName>
                    <ForeName>J</ForeName>
                </Author>
                <Author>
                    <LastName>Sixma</LastName>
                    <ForeName>J J</ForeName>
                </Author>
                <Author>
                    <LastName>Huizinga</LastName>
                    <ForeName>E G</ForeName>
                </Author>
            </Authors>
            <ArticleChemicalList>Antibodies, Monoclonal;Epitopes;Recombinant Proteins;von Willebrand Factor;Histidine;Collagen;Arginine;Alanine</ArticleChemicalList>
            <ArticleMeshHeadingsList>Alanine(chemistry; metabolism); Amino Acid Sequence; Antibodies, Monoclonal(metabolism); Arginine(chemistry); Binding Sites; Collagen(metabolism); Crystallography, X-Ray; Epitopes; Histidine(chemistry); Humans; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Point Mutation; Protein Binding; Protein Conformation; Protein Structure, Tertiary; Recombinant Proteins(chemistry; metabolism); von Willebrand Factor(chemistry; metabolism)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>276</Volume>
                <Issue>13</Issue>
                <Title>The Journal of biological chemistry</Title>
                <Issn>1083-351X</Issn>
                <MedlineTa>J Biol Chem</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>RU5 epitope of A3 domain of von Willebrand factor</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>P1725, R1726, L1727, T1728, Q1729, P1744, W1745, N1746, V1747, V1748, P1749, E1750, K1751, A1752, H1753, L1754, L1755, S1756, L1757, V1758, D1759, V1760, M1785, H1786, G1787, A1788, R1789;</DiscontinuousResidues>
                        <ModifiedResidues>M1785</ModifiedResidues>
                        <Modifications>Side chain modification</Modifications>
                        <SourceMolecule>
                            <GenBankId>P04275.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 3, Table II</LocationOfData>
                <EpitopeId>131327</EpitopeId>
                <ReferenceRegion>P962, R963, L964, T965, Q966, P981, W982, N983, V984, V985, P986, E987, K988, A989, H990, L991, L992, S993, L994, V995, D996, V997, (MSE)1022, H1023, G1024, A1025, R1026;</ReferenceRegion>
                <EpitopeEvidenceCode>Author provided Identifier</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Modified residue M1785 (MSE1022 in PDB numbering [PDB: 1FE8]) is selinomethionine.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Tables 1, 2, and Figures 2, 3, 4 and PDB 1FE8</LocationOfData>
                        <BCellId>1649935</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <ModifiedResidues>M1785</ModifiedResidues>
                                            <Modifications>Side chain modification</Modifications>
                                            <Molecule>
                                                <GenBankId>P04275.3</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The details of the immunization procedure were not described. Monoclonal antibody RU5 was purified from ascites fluid on protein G-Sepharose and Fab fragments were generated.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.03</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The epitope recognized by Fab RU5 bound to the vWF A3 domain was determined by X-ray crystallography. There are three molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex A : Antibody heavy-chain: H, Antibody light-chain: L, epitope chain: A. Complex B : Antibody heavy-chain: I, Antibody light-chain: M, epitope chain: B. Complex C : Antibody heavy-chain: J, Antibody light-chain: N, epitope chain: C. In the three complexes, the RU5/A3 interaction region is well conserved, but relatively large differences are shown in the orientations of the RU5 constant domains with respect to its variable domains and A3. Complexes B and C form a tightly interacting anti-parallel dimer and are related by 2-fold non-crystallographic symmetry. Complex A forms a similar anti-parallel dimer with a crystallographically related complex A'.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>RU5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>RU5</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1FE8_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1FE8_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>vWF A3 domain (Se-Met)</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>APDCSQPLDVILLLDGSSSFPASYFDEMKSFAKAFISKANIGPRLTQVSVLQYGSITTIDVPWNVVPEKAHLLSLVDVMQREGGPSQIGDALGFAVRYLTSEMHGARPGASKAVVILVTDVSVDSVDAAADAARSNRVTVFPIGIGDRYDAAQLRILAGPAGDSNVVKLQRIEDLPTMVTLGNSFLHKLCSG</LinearSequence>
                                        <ModifiedResidues>M1785</ModifiedResidues>
                                        <Modifications>Side chain modification</Modifications>
                                        <StartingPosition>1683</StartingPosition>
                                        <EndingPosition>1874</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P04275.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1FE8</ComplexPdbId>
                            <AntibodyChain1PdbChain>H</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>L</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>A</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>Antibody CDR loops L1 and L2 interact with loops α1β2 and α3β4. All six CDR loops interact with A3 residues in the contiguous segment formed by loop β3α2 and helix α2. Conformational comparison between RU5 Fab/A3 (this structure), unbound A3 [PDB: 1AO3] and unbound A3 [PDB: 1ATZ]  showed that overall, the structure of the A3 molecule is the same as the structures of the unbound A3. There are three conformational diverse loops located in the antibody epitope α1β2, β3α2 and α3β4. Specifically loop α1β2 has a unique conformation in the RU5 Fab/A3 complex, indicating that this conformation is induced by RU5. Also, distant from the RU5 epitope conformational variation is observed for loops β1α1 and α5β6.</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>A: P962, R963, L964, T965, Q966, P981, W982, N983, V984, V985, P986, E987, K988, A989, H990, L991, L992, S993, L994, V995, D996, V997, (MSE)1022, H1023, G1024, A1025, R1026;</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: ; L: ;</AntibodyResiduesInteractingWithAntigen>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>A: P962, R963, Q966, P981, W982, N983, V984, V985, P986, E987, A989, H990, S993, L994, D996, V997, (MSE)1022, H1023, G1024, R1026</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: T30, T31, W52, G53, D54, N56, N98, Y99, Y100, G101; L: D28, I29, G30, N31, Y32, Y50, R53, G68, G91, G92, N94, W96</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>1002.2</ContactAreaForAntigen>
                                <ContactAreaForAntibody>916.8</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 5 and 6</LocationOfData>
                        <BCellId>1755194</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <ModifiedResidues>M1785</ModifiedResidues>
                                            <Modifications>Side chain modification</Modifications>
                                            <Molecule>
                                                <GenBankId>P04275.3</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The details of the immunization procedure were not described. Monoclonal antibody RU5 was purified from ascites fluid on protein G-Sepharose and Fab fragments were generated.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Epitope specific mAb RU5 bound to wild type vWF and to point mutants with alanine substitutions at residue Arg963, Glu987, His990, Arg1016, or His1023. The mutants bound to mAb RU5, but mutation of His1023 almost abolished vWF binding to collagen and mutation of Arg963 or Arg1016 reduced collagen binding 25-35%.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>RU5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>RU5</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1FE8_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1FE8_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>vWF</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <ModifiedResidues>M1785</ModifiedResidues>
                                        <Modifications>Side chain modification</Modifications>
                                        <Molecule>
                                            <GenBankId>P04275.3</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

